throbber
US007608641B2
`
`(12) Ulllted States Patent
`Miller et al.
`
`(10) Patent N0.:
`(45) Date of Patent:
`
`US 7,608,641 B2
`*Oct. 27, 2009
`
`(54) CREATINE ORAL SUPPLEMENTATION
`USING CREATINE HYDROCHLORIDE SALT
`
`(75) Inventors: Donald W. Miller, Winnipeg (CA);
`Jonathan L. Vennerstrom, Omaha, NE
`
`(52) US. Cl. .................................................... .. 514/565
`(58) Field of Classi?cation Search ................ .. 514/565
`See application ?le for complete search history.
`_
`References Clted
`
`(56)
`
`Mark C- Faulkner, Madlson,
`
`5,817,329 A 10/1998 Gardiner
`
`(73) Assignee: Board of Regents of the University of
`Nebraska’ Lincoln’ NE (Us)
`
`( >x< ) Notice:
`
`Subject to any disclaimer, the term ofthis
`patent is extended or adjusted under 35
`U.S.C. 154(b) by 888 days.
`
`This patent is subject to a terminal dis-
`Claimem
`
`_
`(21) Appl' NO" 10/846’782
`
`(22) F1led:
`
`May 14, 2004
`
`6,136,339 A 10/2000 Gardiner
`6,620,425 B1
`9/2003 Gardiner
`6,784,209 B1
`8/2004 Gardiner et a1.
`6,897,334 B2 *
`5/2005 Vennerstrom ............. .. 560/169
`FOREIGN PATENT DOCUMENTS
`
`0222135
`WO
`_
`_
`* cited by examlner
`
`3/2002
`
`Primary ExamineriKevin Weddington
`(74) Attorney, Agent, or FirmiHanify & King, RC.
`
`(57)
`
`ABSTRACT
`
`(65)
`
`Pnor Pubhcatlon Data
`US 2004/0242691 A1
`Dec. 2, 2004
`
`Related U-s- Application Data
`(60) Provisional application No. 60/470,356, ?led on May
`15 2003'
`’
`(51) Int. Cl.
`A61K 31/195
`
`(2006.01)
`
`Creatine oral supplementation using creatine hydrochloride
`salt, that may be added to a liquid or other beverage, or may
`be also used as an additive to solid oral dosages, or as a
`supplement, and Which may be consumed by the athlete, or
`other party lookmg for lmmedlate supplememanon of
`strength, and may be added as a supplement Within feed to
`livestock, in the veterinary area.
`
`7 Claims, N0 Drawings
`
`Vireo Systems, Inc. Ex. 2009 - 001
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`US 7,608,641 B2
`
`1
`CREATINE ORAL SUPPLEMENTATION
`USING CREATINE HYDROCHLORIDE SALT
`
`CROSS REFERENCE TO RELATED
`APPLICATION
`
`This non-provisional patent application claims priority to
`the provisional application for patent having Ser. No. 60/470,
`356, Which Was ?led on May 15, 2003.
`
`BACKGROUND OF THE INVENTION
`
`Dietary supplementation With creatine is an approved and
`accepted means for increasing muscle performance, and
`increasing muscle mass. Most current commercial applica
`tions involving creatine supplementation use the creatine
`monohydrate form as the primary embodiment. A limitation
`of creatine supplements using the creatine monohydrate form
`is that the products have loW aqueous solubility and require
`relatively large doses of creatine be consumed With large
`amounts of ?uid. The physiochemical properties of creatine
`monohydrate are such that oral absorption is limited. There
`are other salt forms including creatine citrate (creatine effer
`vescent) and creatine pyruvate that have been patented and
`marketed as improvements over creatine monohydrate.
`Despite the various salt forms currently marketed, there is an
`unmet need for an improved form of creatine that could be
`taken in a more convenient dosage form and have better oral
`absorption characteristics.
`
`SUMMARY OF THE INVENTION
`
`This invention relates principally to the use of creatine
`hydrochloride salt for application to aqueous solutions foruse
`as a beverage in the sports environment, liquid meal replace
`ment, nutritional energy bars, and other forti?ed foods.
`In essence, this invention relates to the usage of a granular
`precipitate consisting of creatine hydrochloride salt in a high
`purity and yield. More speci?cally, the creatine hydrochlo
`ride salt, When added to a solution, and used as a beverage or
`other form of drink, functions as a nutritional supplement for
`enhancing muscle performance and developing muscle mass
`in both humans and livestock.
`It is, therefore, the principle object of this invention to
`utiliZe creatine hydrochloride salt, apart from other forms of
`creatine, but in this instance, having high aqueous solubility
`so as to readily mix With any liquid, or beverage, and having
`application in the ?eld of athletics to enhance developed and
`generated strength.
`Another object of this invention is the application of hydro
`chloride salts, of creatine form, that may be added as a feed
`additive When fed to livestock, or other animals.
`These and other objects may become more apparent to
`those skilled in the art upon revieW of the summary of the
`invention as provided herein and upon undertaking a study of
`the description of its preferred embodiment.
`
`DESCRIPTION OF THE PREFERRED
`EMBODIMENT
`
`The present invention involves a process for the production
`of the hydrochloride salt form of creatine. The process uses
`creatine monohydrate and acetyl chloride as the reactants
`and, ethanol as the preferred solvent. The product of this
`reaction is a granular precipitate consisting of the creatine
`hydrochloride salt in high purity and yield.
`
`20
`
`25
`
`30
`
`35
`
`45
`
`50
`
`55
`
`60
`
`65
`
`2
`The invention also involves an application or use of the
`creatine hydrochloride salt as a nutritional supplement for
`enhancing muscle performance and muscle mass in both
`humans and livestock. What sets this creatine hydrochloride
`salt apart from the other forms of creatine is its high aqueous
`solubility. Studies in the inventors’ laboratory indicate that
`the aqueous solubility of the creatine hydrochloride is 150
`mg/ml or greater, While that of creatine monohydrate and
`creatine citrate salt is at least an order of magnitude loWer
`(approximately 10-15 mg/ml). As the loW oral absorption of
`creatine supplements are believed to be attributable in part to
`reduced solubility, the creatine hydrochloride Would be
`expected to have better oral absorption properties. An alter
`nate embodiment of the process uses anhydrous creatine. An
`alternate embodiment of the process uses other short chain
`alcohols selected from methanol, propanol, butanol, isopro
`panol, among others to replace the ethanol solvent.
`Various other applications for use With this type of a salt,
`other than in the sports beverage area, may include its appli
`cation as a feed additive in livestock. Certainly, based upon
`What is noW knoWn about the product, it Would have imme
`diate applications in the solid oral dosage supplementation
`area, as an additive or a feed supplement in livestock feed. Or,
`it may be added into a liquid, or any Water, that is fed to the
`livestock, during there consumption of liquids and solids.
`This is contemplated Within the essence of this invention
`that the formulation for the oral supplementation of this
`invention could be provided in a solid oral dosage form, such
`as in a capsule form, or tablets, for treatment requirements
`When taken by the human, animal, and the like. This is knoWn
`in the art. The formulation for the creatine oral supplementa
`tion, using the Creatine Hydrochloride Salt, is CrHCl. The
`formulation could be added into a beverage in addition the
`CrHCl may be provided as an ingredient to a sports drink,
`liquid meal replacement, or the like, and as can be under
`stood. Furthermore, the concept of this invention for use of
`this formulation Within a supplementation can be used and
`applied for nutritional and energy purposes. Furthermore, the
`composition could be added as a forti?cation to other foods.
`Finally, it is likely that this composition could be added as a
`feed supplement, to further enhance the energy requirements
`of the horses, and other animals, as may be desired and
`required.
`The product of this reaction of creatine monohydrate and
`acetyl chloride dissolved in ethanol is a granular precipitate
`consisting of the creatine hydrochloride salt in high purity
`and yield. Yield is measured by 1H-NMR analysis used for
`organic chemicals. 1H-NMR uses spectroscopy and nuclear
`magnetic resonance technology to ascertain the structure of
`chemical compounds.
`The reactants are measured as mole equivalents While the
`solvent is measured as milliliters per gram of creatine hydro
`chloride salt. The preferred process uses 1 .4 mole equivalents
`of acetyl chloride. Above 1.5 and including 2.0 mole equiva
`lents acetyl chloride, the process produces less desirable cre
`atine ethyl ester hydrochloride at a sacri?ce of yield for cre
`atine hydrochloride. Above 2.0 mole equivalents acetyl
`chloride, the process forms creatinine hydrochloride. The
`preferred process dissolves the reactants in 10 ml of ethanol.
`Alternatively, the process has ethanol ranging from about 6 to
`about 10 ml. The preferred process operates in a temperature
`range of 25 deg. C. to 35 deg. C. At temperatures above the
`preferred range including 50 deg. C., the process produces the
`less desirable creatine ethyl ester hydrochloride. In excess of
`50 deg. C., the process produces creatinine hydrochloride.
`
`Vireo Systems, Inc. Ex. 2009 - 002
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`US 7,608,641 B2
`
`3
`However, even in the preferred embodiment minor fractions
`of creatine ethyl ester hydrochloride and creatinine hydro
`chloride are produced.
`To form creatine hydrochloride salt, a manufacturer blends
`creatine monohydrate With acetyl chloride in a vessel. Then
`ethanol is added to the vessel as a solvent. The temperature of
`the solution is raised to betWeen about 24 deg. C. to about 50
`deg. C., preferably to 25 deg. C. In that condition, the solution
`precipitates a hydrochloride salt of creatine in granular form
`in the vessel. After reducing the temperature and pressure to
`ambient atmospheric temperature and pressure, the manufac
`turer collects the granules of creatine hydrochloride salt then
`packages the granules for consumption by humans or live
`stock.
`As an alternative method, a manufacturer produces creat
`ine hydrochloride by bubbling gaseous HCl into diethyl ether
`solvent. Then, creatine monohydrate is stirred into the sol
`vent. From the reaction, creatine hydrochloride precipitates.
`The manufacturer then ?lters and Washes the precipitate.
`Lastly, the precipitate dries at room temperature to a crystal
`line form, White in color and then is packaged for human or
`livestock consumption. In using the alternative method, the
`HCl may have a range of concentrations so long as the HCl
`exceeds the molar equivalent of creatine monohydrate. Next,
`the alternative method stirred from about 0 grams to about 5
`grams of creatine monohydrate into the solution at 25 deg. C.
`for tWo hours. Filtering and Washing Were performed With 50
`milliliters of fresh diethyl ether.
`Variations or modi?cations to the subj ect matter may occur
`to those skilled in the art upon revieW of the invention as
`described herein. Such variations, if Within the spirit of this
`development, are intended to be encompassed Within the
`scope of the invention as de?ned herein. The description of
`the preferred embodiment, as provided, is set forth for illus
`trative purposes only.
`We claim:
`1. A supplement to increase muscle mass and muscle per
`formance consisting of creatine hydrochloride salt formed
`from the reaction product of:
`
`5
`
`20
`
`25
`
`30
`
`4
`about 0.8 to about 1.2 mole equivalent creatine monohy
`drate; and
`about 1.1 to about 1.4 mole equivalents acetyl chloride,
`dissolved in about 6 to about 10 milliliters alcohol solution
`per gram of creatine hydrochloride salt at a temperature
`of about 25° C. to about 35° C.,
`Wherein the supplement has an aqueous solubility of at
`least 150 mg/ml.
`2. The supplement of claim 1, Wherein the reaction product
`is formed from:
`about 1 mole equivalent creatine monohydrate; and
`about 1.4 mole equivalents acetyl chloride dissolved in
`about 10 milliliters ethanol solution.
`3. The supplement of claim 2, Wherein the supplement is
`precipitated as granules and then packaged into an oral dos
`age form.
`4. The supplement of claim 1, Wherein the supplement has
`an aqueous solubility of at least an order of magnitude higher
`than the aqueous solubility of creatine monohydrate.
`5. The supplement of claim 1, Wherein the yield of creatine
`hydrochloride salt is approximately 94 percent.
`6. A supplement for to increase muscle mass and muscle
`performance consisting of creatine hydrochloride salt formed
`from the reaction product of:
`about 1 mole equivalent creatine monohydrate:
`about 1.4 mole equivalents acetyl chloride;
`said creatine monohydrate and said acetyl chloride dissolv
`ing in about 10 milliliters ethanol solution at a tempera
`ture of about 250 C. forming a solution of creatine hydro
`chloride having an aqueous solubility of at least 150
`mg/ml; and
`thus precipitating granules of creatine hydrochloride salt
`from the solution for oral dosage as one pill, capsule,
`tablet, or liquid.
`7. The supplement of claim 6, Wherein the yield of creatine
`hydrochloride salt is approximately 94 percent.
`
`*
`
`*
`
`*
`
`*
`
`*
`
`Vireo Systems, Inc. Ex. 2009 - 003
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket